Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;25(2):170-182.
doi: 10.1634/theoncologist.2019-0600. Epub 2019 Nov 12.

Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review

Affiliations

Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review

Gabriel F P Aleixo et al. Oncologist. 2020 Feb.

Abstract

Background: The loss of muscle mass, known as sarcopenia, is a natural process of aging that is associated with adverse health outcomes regardless of age. Because cancer is a disease of aging, interest in sarcopenia and its potential impact in multiple cancer populations has increased significantly. Bioelectrical impedance analysis (BIA) is a guideline-accepted method for sarcopenia detection. This systematic review assesses the literature pertaining to BIA use in the detection of sarcopenia in adults with cancer.

Materials and methods: In this systematic review, a search of the literature for randomized controlled trials and observational studies was conducted using MEDLINE, Cochrane CENTRAL, and EMBASE, through July 15, 2019. The study is registered at Prospero (CRD 42019130707). For study inclusion, patients had to be aged 18 years or older and diagnosed with solid or hematological neoplasia, and BIA had to be used to detect sarcopenia.

Results: Through our search strategy, 5,045 articles were identified, of which 24 studies were selected for inclusion in the review (total number of 3,607 patients). In five studies, BIA was rated comparable to axial computed tomography (CT) scan, calf circumference, or grip strength for sarcopenia screening. In 14 studies, BIA-identified sarcopenia was associated with adverse clinical outcomes.

Conclusion: BIA is an accurate method for detecting sarcopenia in adults with cancer prior to treatment and is a viable alternative to CT, dual-energy x-ray absorptiometry, and magnetic resonance imaging in oncology clinical practice.

Implications for practice: Bioelectrical impedance analysis (BIA) is an attractive method for identifying sarcopenic patients in clinical practice because it provides an affordable, noninvasive test that can be completed within a few minutes during a clinic visit. BIA does not require highly skilled personnel, and results are immediately available. This systematic review summarizes the literature pertaining to BIA assessment of sarcopenia in adults with cancer, with a focus on its use in diverse cancer populations.

Keywords: Bioimpedance electrical analysis; Cancer; Pretreatment; Sarcopenia.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Figures

Figure 1
Figure 1
PRISMA search.

Similar articles

Cited by

References

    1. Delmonico MJ, Beck DT. The current understanding of sarcopenia: Emerging tools and interventional possibilities. Am J Lifestyle Med 2016;11:167–181. - PMC - PubMed
    1. Cruz‐Jentoft AJ, Bahat G, Bauer J et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019;48:16–31. - PMC - PubMed
    1. Chang SF, Lin PL. Systematic literature review and meta‐analysis of the association of sarcopenia with mortality. Worldviews Evid Based Nurs 2016;13:153–162. - PubMed
    1. National Cancer Institute . Surveillance, Epidemiology, and End Results (SEER) Program. Cancer: SEER Stat Fact Sheets. 2017. Available at https://seer.cancer.gov/statfacts/. Accessed November 1, 2019.
    1. Williams GR, Rier HN, McDonald A et al. Sarcopenia & aging in cancer. J Geriatr Oncol 2019;10:374–377. - PMC - PubMed

Publication types